VigorMeds review

VigorMeds publishes its longevity catalog in full: twelve products with strengths stated and prices attached, spanning NAD⁺ in four routes, glutathione in four, and sermorelin as both a 9 mg injection and a 2 mg oral tablet. Two things stop it short. Every "from $X per month" tile resolves, on the product page itself, to a three-month plan with a promotional discount, so none of those figures is a month-to-month rate. And the NAD⁺ injection page labels the product "FDA - approved medication", which is not true of a compounded NAD⁺ preparation. Raise that with them before you buy.

VigorMeds (Vigormeds LLC) is a patient-management telehealth platform running four verticals — Weight Management, Anti-Aging and Wellness, ED Therapy and Hair Loss Therapy. It states in its own footer that it does not directly provide medical or pharmacy services: medical services are provided by independent providers and OLA Health LLC. Its longevity shelf lists NAD⁺ injections, nasal spray, transdermal patches and face cream; glutathione as injection, oral tablets, nasal spray and patches; sermorelin acetate injection and sermorelin oral tablets; a lipotropic B12 blend; and methylcobalamin. Its weight line covers compounded semaglutide and tirzepatide in injection and sublingual forms, also priced publicly.

A three-step model the site states plainly: complete an online medical form, have a telehealth consultation with a licensed provider to review eligibility, then receive a personalized plan with follow-up guidance. A consultation rather than a pure questionnaire is the better process for injectables. Two structural facts deserve weight. First, the corporate disclaimer is unusually candid — Vigormeds LLC is explicitly a patient-engagement platform, not the medical or pharmacy provider, and it states that payment does not guarantee that a prescription will be written or dispensed. That is honest and it is also a reminder that your clinical relationship is with a third party. Second, the states page is a graphic with three status bands rather than an enumerated list, so you cannot read off whether you are covered. No compounding pharmacy is named anywhere, no medical director is published, and while the footer links to the LegitScript checker for the domain, no certificate number is shown for direct lookup. A 30-day satisfaction guarantee is advertised, with a full refund of the subscription fee.

Published, specific and easy to misread — and one figure on the page is a factual problem rather than a pricing one. The longevity tiles read: NAD⁺ injections from $119 a month at 100 or 200 mg/mL in a 10 mL vial, NAD⁺ nasal spray from $69 at 150 mg/mL in 30 mL, NAD⁺ patches from $199 for six at 400 mg/mL, NAD⁺ face cream from $59; glutathione injection from $149 at 200 mg/mL, glutathione oral tablets from $119, glutathione nasal spray from $60, glutathione patches from $149 for six; sermorelin acetate 9 mg injection from $149; sermorelin oral tablets 2 mg from $89. Stating milligrams beside a price is genuinely useful and we credit it. But open the NAD⁺ injection page and the same $119 appears under a line reading "3 month plan" with a $50-off badge attached, which means the tile price is a discounted prepay tier and not a standing monthly rate. So read every tile figure as a discounted three-month rate, not a monthly price. Ask what the month-to-month rate is once any promotion lapses, and whether the discount applies to the first cycle only.

Compounded; not FDA-approved — and this is where the site contradicts itself. Its NAD⁺ injection product page carries the label "FDA - approved medication" above the price. That is wrong. Compounded NAD⁺ injections are pharmacy-prepared preparations; they are not FDA-approved drug products and have not been reviewed by the FDA for safety, effectiveness or quality, and compounded sterile products are not reviewed for purity and potency the way approved drugs are. A reader who takes that label at face value is being told the opposite of the truth about what they are buying, so treat it as an error to challenge rather than a claim to rely on. On the underlying evidence: injected NAD⁺ has no controlled human outcome trials at all, and intranasal and transdermal NAD⁺ have less pharmacokinetic support still — the NAD⁺ forms with human trial data are the oral precursors NR and NMN, which raise a blood level rather than demonstrate a benefit. Sermorelin is a GHRH analog with a real mechanism and thin long-term outcome data. Injectable glutathione has essentially no controlled human outcome data behind the antioxidant and detoxification claims made for it. Individual results vary.